Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spero Therapeutics (SPRO) Preferred Dividend Payments (2016 - 2017)

Spero Therapeutics' Preferred Dividend Payments history spans 2 years, with the latest figure at $833000.0 for Q4 2017.

  • For Q4 2017, Preferred Dividend Payments fell 9.26% year-over-year to $833000.0; the TTM value through Dec 2017 reached $6.1 million, changed N/A, while the annual FY2017 figure was $6.1 million, 78.61% up from the prior year.
  • Preferred Dividend Payments reached $833000.0 in Q4 2017 per SPRO's latest filing, down from $2.1 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $2.1 million in Q3 2017 to a low of $833000.0 in Q4 2017.